Investigator Sponsored Phase I/II study of AXL1717 in Patients with Brain Tumors
Thursday, April 25, 2013
Phase I/II study with AXL1717 started in the United States.
Horizon and Boehringer Ingelheim Enter Oncology Research Service Collaboration
Tuesday, April 23, 2013
Five year collaboration will support Boehringer Ingelheim’s drug discovery programs.
Dr. Hashim M. Al-Hashimi Receives Agilent Thought Leader Award
Tuesday, April 23, 2013
Agilent supports University of Michigan Professor’s work developing transformative NMR applications for structural biology.
Researchers Abuzz Over Caffeine as Cancer-Cell Killer
Tuesday, April 23, 2013
UAlberta research team uses caffeine and fruit flies to pinpoint genetic pathways that guide DNA repair in cancer cells.
Singapore Scientist Wins Coveted Chen New Investigator Award 2013
Tuesday, April 23, 2013
Dr Patrick Tan is lauded for his significant contributions to the research on genomic profiles of Asian cancers.
Algeta’s Partner Bayer Submits Radium-223 for EU Marketing Authorization
Monday, April 22, 2013
Submission to trigger €50 million milestone payment to Algeta.
Horizon Announces Oncology Drug Discovery Collaboration with AstraZeneca
Monday, April 22, 2013
Agreement to explore Horizon’s first-in-class kinase target programme, HD-001.
Galapagos Discovers Novel Candidate Drug to Treat Breast Cancer
Monday, April 22, 2013
GLPG1790 has high efficacy against triple-negative breast cancer.
Scientists Throw New Light on DNA Copying Process
Monday, April 22, 2013
Research has thrown new light on the way breakdowns in the DNA copying process inside cells can contribute to cancer and other diseases.
|
|
|
|
|
|
